Page last updated: 2024-09-04

gadofosveset trisodium and Cardiovascular Stroke

gadofosveset trisodium has been researched along with Cardiovascular Stroke in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botnar, RM; Dong, X; Lavin, B; Lorrio, S; Phinikaridou, A; Protti, A; Shah, A1
Fleck, E; Kelle, S; Kokocinski, T; Nagel, E; Schnackenburg, B; Thouet, T1

Trials

1 trial(s) available for gadofosveset trisodium and Cardiovascular Stroke

ArticleYear
Visualization of chronic myocardial infarction using the intravascular contrast agent MS-325 (gadofosveset) in patients.
    TheScientificWorldJournal, 2012, Volume: 2012

    Topics: Adult; Aged; Chronic Disease; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Myocardial Infarction; Organometallic Compounds

2012

Other Studies

1 other study(ies) available for gadofosveset trisodium and Cardiovascular Stroke

ArticleYear
MRI with gadofosveset: A potential marker for permeability in myocardial infarction.
    Atherosclerosis, 2018, Volume: 275

    Topics: Animals; Capillary Permeability; Contrast Media; Coronary Vessels; Disease Models, Animal; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging, Cine; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Organometallic Compounds; Predictive Value of Tests; Time Factors; Ventricular Function, Left; Ventricular Remodeling

2018